ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease-An Update

J Crohns Colitis. 2017 Jan;11(1):26-34. doi: 10.1093/ecco-jcc/jjw198. Epub 2016 Dec 7.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Biosimilar Pharmaceuticals / therapeutic use*
  • Drug Substitution / standards
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Inflammatory Bowel Diseases / drug therapy*
  • Infliximab / therapeutic use
  • Treatment Outcome

Substances

  • Biosimilar Pharmaceuticals
  • Gastrointestinal Agents
  • Infliximab